Novartis expects the new capacity will allow it to produce all of its key medicines “end to end” in the U.S., as the Trump ...

Swiss pharmaceutical giant Novartis said it plans to invest $23 billion in the construction and expansion of U.S. facilities, ...

A Swiss drug giant has gotten the message from President Trump’s tariff threats. Novartis said Thursday it will spend $23 billion over the next five years to expand its footprint in the U.S. The ...

With US tariffs on pharmaceuticals likely to come 'very soon,' another of the world's largest drugmakers is announcing plans ...

On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the ...

By Patrick Wingrove (Reuters) -Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 ...

Swiss pharmaceutical giant Novartis AG said it would invest $23 billion in the US over the next five years to ensure all its ...

Pharmaceutical company Novartis said it plans to expand U.S.-based manufacturing and research and development, with a total investment of $23 billion over the next five years.

Swiss drugmaker Novartis plans a $23 billion investment in building and expanding 10 manufacturing and research facilities in the U.S. This move aligns with their U.S.-first strategy amid looming ...

Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it ...